CHEMERIN AS A POTENTIAL REGULATOR OF MITOCHONDRIAL QUALITY CONTROL IN OBESE PATIENTS

In obese patients, the relationship between the content of chemerin in blood plasma and the expression of genes TFAM, Drp1, MFN2, SOD, BAX, responsible for quality control of mitochondria, in insulin-dependent tissues (adipose tissue, liver) was revealed. The tissue-specific features of gene express...

Full description

Bibliographic Details
Main Authors: M. A. Vulf, D. A. Shunkina (Skuratovskaia), V. Hung, A. A. Komar, P. A. Zatolokin, E. V. Kirienkova, N. D. Gazatova, L. S. Litvinova
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2021-10-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/2433
_version_ 1797197890235400192
author M. A. Vulf
D. A. Shunkina (Skuratovskaia)
V. Hung
A. A. Komar
P. A. Zatolokin
E. V. Kirienkova
N. D. Gazatova
L. S. Litvinova
author_facet M. A. Vulf
D. A. Shunkina (Skuratovskaia)
V. Hung
A. A. Komar
P. A. Zatolokin
E. V. Kirienkova
N. D. Gazatova
L. S. Litvinova
author_sort M. A. Vulf
collection DOAJ
description In obese patients, the relationship between the content of chemerin in blood plasma and the expression of genes TFAM, Drp1, MFN2, SOD, BAX, responsible for quality control of mitochondria, in insulin-dependent tissues (adipose tissue, liver) was revealed. The tissue-specific features of gene expression (TFAM, Drp1, MFN2, SOD, BAX), the number of mtDNA copies in the studied depots in obese patients were established. It has been proven that a change (decrease) in the number of mtDNA copies in insulin-dependent tissues can have a protective effect on mitochondria under conditions of increased oxidative stress. It was found that in patients without type 2 diabetes, an increase in chemerin production promotes the activation of the antioxidant system in the visceral adipose tissue but not in the liver. On the contrary, all obese patients with type 2 diabetes showed a decrease (compared with patients without type 2 diabetes) in the plasma level of chemerin. Thus, the low content of chemerin in the blood plasma in patients with type 2 diabetes mediates the formation of mitochondrial dysfunction in insulin-dependent tissues (adipose tissue, liver).
first_indexed 2024-03-08T05:47:46Z
format Article
id doaj.art-6e3c5b1a82214d2f8e68ce273de571ad
institution Directory Open Access Journal
issn 1563-0625
2313-741X
language Russian
last_indexed 2024-04-24T06:51:09Z
publishDate 2021-10-01
publisher St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
record_format Article
series Медицинская иммунология
spelling doaj.art-6e3c5b1a82214d2f8e68ce273de571ad2024-04-22T13:07:47ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2021-10-0123488188610.15789/1563-0625-CAA-22271460CHEMERIN AS A POTENTIAL REGULATOR OF MITOCHONDRIAL QUALITY CONTROL IN OBESE PATIENTSM. A. Vulf0D. A. Shunkina (Skuratovskaia)1V. Hung2A. A. Komar3P. A. Zatolokin4E. V. Kirienkova5N. D. Gazatova6L. S. Litvinova7Immanuel Kant Baltic Federal UniversityImmanuel Kant Baltic Federal UniversityImmanuel Kant Baltic Federal UniversityImmanuel Kant Baltic Federal UniversityImmanuel Kant Baltic Federal UniversityImmanuel Kant Baltic Federal UniversityImmanuel Kant Baltic Federal UniversityImmanuel Kant Baltic Federal UniversityIn obese patients, the relationship between the content of chemerin in blood plasma and the expression of genes TFAM, Drp1, MFN2, SOD, BAX, responsible for quality control of mitochondria, in insulin-dependent tissues (adipose tissue, liver) was revealed. The tissue-specific features of gene expression (TFAM, Drp1, MFN2, SOD, BAX), the number of mtDNA copies in the studied depots in obese patients were established. It has been proven that a change (decrease) in the number of mtDNA copies in insulin-dependent tissues can have a protective effect on mitochondria under conditions of increased oxidative stress. It was found that in patients without type 2 diabetes, an increase in chemerin production promotes the activation of the antioxidant system in the visceral adipose tissue but not in the liver. On the contrary, all obese patients with type 2 diabetes showed a decrease (compared with patients without type 2 diabetes) in the plasma level of chemerin. Thus, the low content of chemerin in the blood plasma in patients with type 2 diabetes mediates the formation of mitochondrial dysfunction in insulin-dependent tissues (adipose tissue, liver).https://www.mimmun.ru/mimmun/article/view/2433obesityt2dmmitochondriachemerinliveradipose tissuemtdna
spellingShingle M. A. Vulf
D. A. Shunkina (Skuratovskaia)
V. Hung
A. A. Komar
P. A. Zatolokin
E. V. Kirienkova
N. D. Gazatova
L. S. Litvinova
CHEMERIN AS A POTENTIAL REGULATOR OF MITOCHONDRIAL QUALITY CONTROL IN OBESE PATIENTS
Медицинская иммунология
obesity
t2dm
mitochondria
chemerin
liver
adipose tissue
mtdna
title CHEMERIN AS A POTENTIAL REGULATOR OF MITOCHONDRIAL QUALITY CONTROL IN OBESE PATIENTS
title_full CHEMERIN AS A POTENTIAL REGULATOR OF MITOCHONDRIAL QUALITY CONTROL IN OBESE PATIENTS
title_fullStr CHEMERIN AS A POTENTIAL REGULATOR OF MITOCHONDRIAL QUALITY CONTROL IN OBESE PATIENTS
title_full_unstemmed CHEMERIN AS A POTENTIAL REGULATOR OF MITOCHONDRIAL QUALITY CONTROL IN OBESE PATIENTS
title_short CHEMERIN AS A POTENTIAL REGULATOR OF MITOCHONDRIAL QUALITY CONTROL IN OBESE PATIENTS
title_sort chemerin as a potential regulator of mitochondrial quality control in obese patients
topic obesity
t2dm
mitochondria
chemerin
liver
adipose tissue
mtdna
url https://www.mimmun.ru/mimmun/article/view/2433
work_keys_str_mv AT mavulf chemerinasapotentialregulatorofmitochondrialqualitycontrolinobesepatients
AT dashunkinaskuratovskaia chemerinasapotentialregulatorofmitochondrialqualitycontrolinobesepatients
AT vhung chemerinasapotentialregulatorofmitochondrialqualitycontrolinobesepatients
AT aakomar chemerinasapotentialregulatorofmitochondrialqualitycontrolinobesepatients
AT pazatolokin chemerinasapotentialregulatorofmitochondrialqualitycontrolinobesepatients
AT evkirienkova chemerinasapotentialregulatorofmitochondrialqualitycontrolinobesepatients
AT ndgazatova chemerinasapotentialregulatorofmitochondrialqualitycontrolinobesepatients
AT lslitvinova chemerinasapotentialregulatorofmitochondrialqualitycontrolinobesepatients